ISPC · Insider Trading
iSpecimen Inc. Common Stock
Every open-market purchase and sale reported by ISPC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-30 | Avtar Dhaliwal | Director | A | +168 deriv. | — |
| 2024-09-27 | Richard Paolone | Director | A | +168 deriv. | — |
| 2024-09-27 | Katharyn Field | Director | A | +168 deriv. | — |
| 2024-05-20 | Steven R. Ph.D. Gullans | Director | A | +10,000 deriv. | — |
| 2024-05-20 | John L. Brooks III | Director | A | +10,000 deriv. | — |
| 2024-05-20 | Andrew L. Ross | Director | A | +10,000 deriv. | — |
| 2024-05-20 | Theresa L Mock | Director | A | +10,000 deriv. | — |
| 2024-05-20 | Elizabeth Ames Graham | Director | A | +8,340 deriv. | — |
| 2023-09-15 | Benjamin Bielak | Chief Info Officer & Secretary | Buy | +18,000 | +$12.96K |
| 2023-06-01 | Tracy Curley | CEO, CFO and Treasurer | Buy | +4,400 | +$5.50K |
| 2023-05-17 | Christopher Ianelli | Director | A | +92 | — |
| 2023-05-17 | Jill Mullan | Director | A | +92 | — |
| 2023-05-17 | Andrew L. Ross | Director | A | +125 | — |
| 2023-05-17 | John L. Brooks III | Director | A | +125 | — |
| 2023-05-17 | Steven R. Ph.D. Gullans | Director | A | +125 | — |
| 2023-05-17 | Joseph J. Basile | Director | A | +63 | — |
| 2023-01-19 | Jill Mullan | Director | M | +66,637 | +$66.64K |
| 2023-01-19 | Christopher Ianelli | Director | M | +845 | +$845 |
| 2023-01-19 | Jill Mullan | Director | A | +10,000 deriv. | — |
| 2023-01-13 | Steven R. Ph.D. Gullans | Director | A | +10,000 deriv. | — |
| 2023-01-13 | Joseph J. Basile | Director | A | +10,000 deriv. | — |
| 2023-01-13 | John L Brooks | Director | A | +10,000 deriv. | — |
| 2023-01-13 | Andrew L. Ross | Director | A | +10,000 deriv. | — |
| 2023-01-13 | George H. Scholl | Director | A | +10,000 deriv. | — |
| 2022-11-14 | Christopher Ianelli | Director | J | −18,229 | — |
| 2022-11-10 | Jill Mullan | Director | J | −18,229 | — |
| 2022-11-04 | Benjamin Bielak | Chief Information Officer | A | +30,000 deriv. | — |
| 2022-11-04 | Tracy Curley | Interim CEO, CFO and Treasurer | A | +100,000 deriv. | — |
| 2022-06-24 | Christopher Ianelli | CEO and President | F | −3,903 | −$9.21K |
| 2022-06-24 | Benjamin Bielak | Chief Information Officer | F | −3,148 | −$7.43K |
| 2022-06-24 | Jill Mullan | COO and Secretary | F | −3,124 | −$7.37K |
| 2022-06-24 | Tracy Curley | CFO and Treasurer | F | −2,738 | −$6.46K |
| 2022-02-24 | Christopher Ianelli | President & CEO | M | +51,205 | +$51.20K |
| 2022-02-23 | Jill Mullan | COO & Secretary | M | +22,395 | +$22.39K |
| 2021-11-29 | Andrew L. Ross | Director | Buy | +4,000 | +$22.38K |
| 2021-11-17 | Tracy Curley | Chief Financial Officer | Buy | +10,000 | +$52.08K |
| 2021-06-23 | Christopher Ianelli | CEO, President | C | +2,663 | — |
| 2021-06-23 | Jill Mullan | COO, Secretary, Treasurer | C | +83,147 | — |
| 2021-06-23 | George H. Scholl | Director | C | +1,683,962 | — |
| 2021-06-23 | Andrew L. Ross | Director | C | +946,183 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ISPC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.